159 related articles for article (PubMed ID: 24147567)
1. Current status and future trends in cervical cancer screening.
Castle P; Dowdall M
Womens Health (Lond); 2014 Mar; 10(2):129-33. PubMed ID: 24147567
[No Abstract] [Full Text] [Related]
2. Self-sampling for high-risk human papillomavirus detection: future cervical cancer screening?
Daponte A; Pournaras S; Tsakris A
Womens Health (Lond); 2014 Mar; 10(2):115-8. PubMed ID: 24601801
[No Abstract] [Full Text] [Related]
3. Study points to value of HPV screening for cervical cancer: test may be viable alternative to Pap test.
Printz C
Cancer; 2014 Dec; 120(23):3589-90. PubMed ID: 25410486
[No Abstract] [Full Text] [Related]
4. Is it time to introduce HPV self-sampling for primary cervical cancer screening?
Petignat P; Vassilakos P
J Natl Cancer Inst; 2012 Feb; 104(3):166-7. PubMed ID: 22271766
[No Abstract] [Full Text] [Related]
5. Can the test for human papillomavirus DNA be used as the stand-alone, first-line screening test for cervical cancer?
Jin XW; McKenzie ML; Yen-Lieberman B
Cleve Clin J Med; 2015 Apr; 82(4):213-5. PubMed ID: 25955454
[No Abstract] [Full Text] [Related]
6. The role of self-collection devices for cytology and human papillomavirus DNA testing in cervical cancer screening.
Bidus MA; Zahn CM; Maxwell GL; Rodriguez M; Elkas JC; Rose GS
Clin Obstet Gynecol; 2005 Mar; 48(1):127-32. PubMed ID: 15725865
[No Abstract] [Full Text] [Related]
7. Rightsizing cervical cancer screening: comment on "Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone".
Sawaya GF
Arch Intern Med; 2010 Jun; 170(11):985-6. PubMed ID: 20548012
[No Abstract] [Full Text] [Related]
8. [Papsmears: An endless story of an announced death?].
Cochand-Priollet B
Ann Pathol; 2019 Dec; 39(6):375-377. PubMed ID: 31839115
[No Abstract] [Full Text] [Related]
9. Screening for Cervical Cancer: New Tools and New Opportunities.
Learman LA; Garcia FAR
JAMA; 2018 Aug; 320(7):647-649. PubMed ID: 30140859
[No Abstract] [Full Text] [Related]
10. Cervical cancer screening today. The role of HPV DNA testing.
Berman NR
Adv Nurse Pract; 2006 Apr; 14(4):24-9; quiz 30. PubMed ID: 16972469
[No Abstract] [Full Text] [Related]
11. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
Miller RA; Mody DR; Tams KC; Thrall MJ
Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer self-sampling tests could improve access.
Printz C
Cancer; 2019 May; 125(10):1583. PubMed ID: 31026075
[No Abstract] [Full Text] [Related]
13. [Screening of cervical cancer--update].
Dvorák V; Ondrus J
Ceska Gynekol; 2010 Feb; 75(1):65-8. PubMed ID: 20437841
[TBL] [Abstract][Full Text] [Related]
14. Cervical screening: primary human papillomavirus testing.
Cruickshank ME; Cubie HA
BJOG; 2012 May; 119(6):650-2. PubMed ID: 22489759
[No Abstract] [Full Text] [Related]
15. A Groundbreaking Work Which Laid the Foundation for Mass Screening in Cervical Cytology in Japan.
Osamura RY
Acta Cytol; 2017; 61(4-5):299-304. PubMed ID: 28693014
[TBL] [Abstract][Full Text] [Related]
16. Screening for Cervical Cancer.
Jin J
JAMA; 2018 Aug; 320(7):732. PubMed ID: 30140878
[No Abstract] [Full Text] [Related]
17. Implementation of a real-time reference and calibration grid platform for improved screening - mapping in Pap test slides.
Tsiambas E; Riziotis C
Pathol Int; 2017 Jan; 67(1):24-31. PubMed ID: 27891686
[TBL] [Abstract][Full Text] [Related]
18. Translational approaches to improving cervical screening.
Baldwin P; Laskey R; Coleman N
Nat Rev Cancer; 2003 Mar; 3(3):217-26. PubMed ID: 12612656
[TBL] [Abstract][Full Text] [Related]
19. Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women.
Bosgraaf RP; Ketelaars PJ; Verhoef VM; Massuger LF; Meijer CJ; Melchers WJ; Bekkers RL
Prev Med; 2014 Jul; 64():108-13. PubMed ID: 24736093
[TBL] [Abstract][Full Text] [Related]
20. Criticism of the Pap Smear as a Diagnostic Tool in Cervical Cancer Screening.
Schneider V
Acta Cytol; 2017; 61(4-5):338-344. PubMed ID: 28693015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
